With the lumpy skin disease killing over 67,000 cattle since its outbreak in July, the Maharashtra government said the vaccination drive against it would be completed in 48 hours in the affected villages in the state.
According to a report by The Indian Express, the state animal husbandry commissioner, Sachindra Pratap Singh said a preventive vaccination drive against Lumpy Skin Disease (LSD) will be completed in 48 hours.
Maharashtra first reported the disease on August 4 in Chinawal village of Raver taluka in Jalgaon district. The disease has since been noticed in as many as 280 villages in Jalgaon, Ahmednagar, Akola, Dhule, Pune, Latur, Aurangabad, Beed, Satara, Buldana, Amravati, Osmanabad, Kolhapur and Sangli, among others.
Meanwhile, speaking to PTI, Animal Husbandry and Dairying Department Secretary Jatindra Nath Swain said states are currently using the ‘goat pox’ vaccine to control lumpy skin disease in cattle.
The commercial launch of a new vaccine ‘Lumpi-ProVacInd’ for LSD, developed by two institutes of agri research body ICAR, will take the next “three-four months,” he said. The lumpy skin disease has spread mainly in Gujarat, Rajasthan, Punjab, Haryana, Uttar Pradesh, Uttarakhand, Madhya Pradesh and Jammu & Kashmir. There are some stray cases in Andhra Pradesh and Andaman & Nicobar Islands.
“In Rajasthan, the number of death is 600-700 per day. But in other states, it is less than 100 in a single day,” he said, adding that the ministry has asked states to accelerate the vaccination process. According to Swain, the goat pox vaccine is “100 per cent effective” and already 1.5 crore doses have been administered in the affected states.
He also said there is a sufficient supply of goat pox vaccine in the country. Two companies are manufacturing this vaccine and they have the capacity to produce 4 crore doses a month. The total cattle population is around 20 crore. Already, 1.5 crore goat pox doses have been given, he said.
While only 1 ml dose of the goat pox vaccine is sufficient to help fight LSD in areas where no case has been reported, doses of 3 ml each can be administered in cattle where an outbreak has been reported, he added. With regard to the new vaccine, Swain said the commercial launch of “Lumpi-ProVacInd” would take the next “three-four months.” “The manufacturers will have to take permission from the Drugs Controller General of India (DCGI) for commercial production of the new vaccine. It will take next 3-4 months for commercial launch,” he added.
On the impact of LSD on milk production, the managing director of Gujarat Cooperative Milk Marketing Federation (GCMMF), which markets dairy products under the Amul brand, R S Sodhi said there has been a marginal impact of 0.5 per cent on milk production in Gujarat. The situation in Gujarat is under control because of the vaccination process, he added.
Sodhi said the impact could be a little higher in other states. “The procurement of organised milk producers including Amul has gone down compared to the year-ago period. But this cannot be attributed to LSD. Unlike last year, unorganised players, sweet makers and hotels are aggressively procuring milk,” he said. Mother Dairy MD Manish Bandlish said, “There is a minor impact on production in the overall scheme of things.” LSD entered India, Bangladesh and China in July 2019. Lumpy skin disease (LSD) is a contagious viral disease that affects cattle and causes fever, and nodules on the skin and can also lead to death. The disease gets spread by mosquitoes, flies, lice, and wasps by direct contact among the cattle, and through contaminated food and water.
India, the world’s largest milk producer, had a cattle population of 192.5 million in 2019, as per the 19th Livestock census.
(With inputs from PTI)
Read all the Latest Business News and Breaking News here